High vs low omega‐3 fats
- Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes onlyno estimate extracted30 studies · 46604 participantsHigh
High probably leads to higher live birth rate ‐ high vs low or no hyaluronic acid compared with low or no hyaluronic acid (moderate certainty).
High probably leads to higher clinical pregnancy rate ‐ high vs low or no hyaluronic acid compared with low or no hyaluronic acid (moderate certainty).
High showed no clear difference in mortality compared with non‐high (medium or low) dose regimen (low certainty).
High showed no clear difference in rebleeding compared with non‐high (medium or low) dose regimen (low certainty).
High showed no clear difference in surgery compared with non‐high (medium or low) dose regimen (low certainty).
High showed no clear difference in further EHT compared with non‐high (medium or low) dose regimen (low certainty).
It is very uncertain whether high changes acute kidney injury compared with low blood pressure target (very low certainty).
High showed no clear difference in cognitive deterioration compared with low blood pressure target (low certainty).
It is very uncertain whether high changes all‐cause mortality compared with low blood pressure target (very low certainty).
It is very uncertain whether high changes quality of life compared with low blood pressure target (very low certainty).
It is very uncertain whether high changes acute ischaemic stroke compared with low blood pressure target (very low certainty).
It is very uncertain whether high changes necrotising enterocolitis compared with standard volume of unfortified human milk or term formula (very low certainty).